January 18, 2026

Marijuana Use in Pregnancy Linked to Emotional Problems in Children

A recent study indicates that maternal marijuana use during pregnancy correlates with increased social and emotional challenges in offspring. Legalization trends have led patients to delay cessation during fertility treatments, despite cannabis remaining a Schedule I drug. The research highlights the need for clearer guidance on substance use impacts during pregnancy.


Key Takeaways

Social and Emotional Development Risks in Children of Mothers Using Marijuana

Maternal cannabis consumption during pregnancy is associated with heightened risks of behavioral issues and emotional dysregulation in children, according to the study. Researchers emphasize that even with legalization, cannabis remains a controlled substance with documented developmental consequences.

Impact of Cannabis Legalization on Pregnancy Decision-Making

Legalization campaigns often mislead patients into perceiving marijuana as safe, influencing reluctance to stop use during fertility treatments. Clinicians report resistance from patients who associate legalization with medical approval, despite lacking evidence of safety during pregnancy.

Fertility Workup Challenges With Cannabis Users

Healthcare providers face difficulties counseling patients on cannabis cessation due to entrenched perceptions of legality equating safety. The study recommends integrating substance use education into fertility consultations to address misconceptions.

Need for Further Research on Cannabis and Neonatal Outcomes

This study suggests a gap in long-term data on cannabis-exposed pregnancies. Researchers call for multi-center trials to quantify risks across demographics, including dosage, timing, and delivery methods of marijuana use.

Healthcare Provider Role in Cannabis Education for Pregnant Patients

Physicians must proactively address cannabis use in prenatal care, emphasizing evidence-based risks. The study advocates for standardized protocols linking cannabis use assessment to pediatric follow-up to monitor developmental outcomes.


Source: Read full article